NCT00430781 / 2006-000236-27: Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer |
|
|
| Completed | 2 | 228 | US, Canada, Europe, RoW | pazopanib (GW786034), lapatinib (GW572016) | GlaxoSmithKline | Neoplasms, Uterine Cervix, Metastatic Cervical Cancer | 07/08 | 07/11 | | |
NCT00316407: Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients |
|
|
| Completed | 1/2 | 30 | US | lapatinib (GW572016), Tykerb, Carboplatin, Paraplatin, Paclitaxel, Taxol | Swedish Medical Center, GlaxoSmithKline | Ovarian Epithelial Cancer Stage III, Stage IV Ovarian Cancer, Stage IV Breast Cancer | 11/09 | 11/09 | | |
